C-reactive protein in midlife is associated with depressive symptoms two decades later among men with coronary heart disease

References

• Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci. 2003;58(3):249–265.
   PubMed Web of Science ®Google Scholar
• Polyakova M, Sonnabend N, Sander C, et al. Prevalence of minor depression in elderly persons with and without mild cognitive impairment: a systematic review. J Affect Disord. 2014;152–154:28–38.
   PubMed Web of Science ®Google Scholar
• McGuire LC, Strine TW, Allen RS, et al. The Patient Health Questionnaire 8: current depressive symptoms among U.S. older adults, 2006 Behavioral Risk Factor Surveillance System. Am J Geriatr Psychiatry. 2009;17(4):324–334.
   PubMed Web of Science ®Google Scholar
• Yaffe K, Edwards ER, Covinsky KE, Lui LY, et al. Depressive symptoms and risk of mortality in frail, community-living elderly persons. Am J Geriatr Psychiatry. 2003;11(5):561–567.
   PubMed Web of Science ®Google Scholar
• Calati R, Salvina Signorelli M, Balestri M, et al. Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. J Affect Disord. 2013;147(1-3):1–8.
   PubMed Web of Science ®Google Scholar
• Valenzuela M, Brayne C, Sachdev P, et al. Cognitive lifestyle and long-term risk of dementia and survival after diagnosis in a multicenter population-based cohort. Am J Epidemiol. 2011;173(9):1004–1012.
   PubMed Web of Science ®Google Scholar
• Jiang W, Kuchibhatla M, Cuffe MS, et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation. 2004;110(22):3452–3456.
   PubMed Web of Science ®Google Scholar
• Strik JJ, Lousberg R, Cheriex EC, et al. One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. J Psychosom Res. 2004;56(1):59–66.
   PubMed Web of Science ®Google Scholar
• Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):953–962.
   PubMed Web of Science ®Google Scholar
• AlBadri A, Lai K, Wei J, et al. Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: a report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). PloS One. 2017;12(5):e0177684.
   PubMed Web of Science ®Google Scholar
• Moylan S, Maes M, Wray NR, et al. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry. 2013;18(5):595–606.
   PubMed Web of Science ®Google Scholar
• Skala JA, Freedland KE, Carney RM. Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry. 2006;51(12):738–745.
   PubMed Web of Science ®Google Scholar
• Duivis HE, de Jonge P, Penninx BW, et al. Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry. 2011;168(9):913–920.
   PubMed Web of Science ®Google Scholar
• Penninx BW, Kritchevsky SB, Yaffe K, et al. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry. 2003;54(5):566–572.
   PubMed Web of Science ®Google Scholar
• Tiemeier H, Hofman A, van Tuijl HR, et al. Inflammatory proteins and depression in the elderly. Epidemiology. 2003;14(1):103–107.
   PubMed Web of Science ®Google Scholar
• Milaneschi Y, Corsi AM, Penninx BW, et al. Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study. Biol Psychiatry. 2009;65(11):973–978.
   PubMed Web of Science ®Google Scholar
• Cattaneo A, Gennarelli M, Uher R, et al. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacol. 2013;38(3):377–385.
   PubMed Web of Science ®Google Scholar
• Goldbourt U, Behar S, Reicher-Reiss H, et al. Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial). Am J Cardiol. 1993;71(11):909–915.
   PubMed Web of Science ®Google Scholar
• Goldbourt U, Brunner D, Behar S, et al. Baseline characteristics of patients participating in the Bezafibrate Infarction Prevention (BIP) Study. Eur Heart J. 1998;19 (Suppl H):H42–7.
   PubMed Web of Science ®Google Scholar
• Almeida OP, Almeida SA. Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriat Psychiatry. 1999;14(10):858–865.
   PubMed Web of Science ®Google Scholar
• Muller M, Voges M, Piepgras U, et al. Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. A comparison with acetazolamide as vasodilatory stimulus. Stroke. 1995;26:96–100.
   PubMed Web of Science ®Google Scholar
• Dwolatzky T, Whitehead V, Doniger GM, et al. Validity of a novel computerized cognitive battery for mild cognitive impairment. BMC Geriatr. 2003;3(1):4.
   PubMedGoogle Scholar
• Lutski M, Haratz S, Weinstein G, et al. Impaired cerebral hemodynamics and frailty in patients with cardiovascular disease. J Gerontol A Biol Sci Med Sci. 2018;73(12):1714–1721.
   PubMed Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.
   PubMed Web of Science ®Google Scholar
• Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550–560.
   PubMed Web of Science ®Google Scholar
• Armstrong NM, Meoni LA, Carlson MC, et al. Cardiovascular risk factors and risk of incident depression throughout adulthood among men: the Johns Hopkins Precursors Study. J Affect Disord. 2017;214:60–66.
   PubMed Web of Science ®Google Scholar
• Reichenberg A, Yirmiya R, Schuld A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001;58(5):445–452.
   PubMed Web of Science ®Google Scholar
• Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34.
   PubMed Web of Science ®Google Scholar
• Garcia-Bueno B, Caso JR, Leza JC. Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neurosci Biobehav Rev. 2008;32:1136–1151.
   PubMed Web of Science ®Google Scholar
• Wium-Andersen MK, Orsted DD, Nielsen SF, et al. Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiatry. 2013;70(2):176–184.
   PubMed Web of Science ®Google Scholar
• Benros ME, Waltoft BL, Nordentoft M, et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry. 2013;70(8):812–820.
   PubMed Web of Science ®Google Scholar
• Khandaker GM, Pearson RM, Zammit S, et al. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014;71(10):1121–1128.
   PubMed Web of Science ®Google Scholar
• Zalli A, Jovanova O, Hoogendijk WJ, et al. Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology. 2016;233(9):1669–1678.
   PubMed Web of Science ®Google Scholar
• Mankovsky BN, Metzger BE, Molitch ME, et al. Cerebrovascular disorders in patients with diabetes mellitus. J Diabetes Complications. 1996;10(4):228–242.
   PubMed Web of Science ®Google Scholar
• Gimeno D, Kivimaki M, Brunner EJ, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009;39(3):413–423.
   PubMed Web of Science ®Google Scholar
• Forti P, Rietti E, Pisacane N, et al. Blood inflammatory proteins and risk of incident depression in the elderly. Dement Geriatr Cogn Disord. 2010;29(1):11–20.
   PubMed Web of Science ®Google Scholar
• Soysal P, Veronese N, Thompson T, et al. Relationship between depression and frailty in older adults: A systematic review and meta-analysis. Ageing Res Rev. 2017;36:78–87.
   PubMed Web of Science ®Google Scholar
• Soysal P, Stubbs B, Lucato P, et al. Inflammation and frailty in the elderly: A systematic review and meta-analysis. Ageing Res Rev. 2016;31:1–8.
   PubMed Web of Science ®Google Scholar
• Newson RS, Hek K, Luijendijk HJ, et al. Atherosclerosis and incident depression in late life. Arch Gen Psychiatry. 2010;67(11):1144–1151.
   PubMed Web of Science ®Google Scholar
• Mast BT, Miles T, Penninx BW, et al. Vascular disease and future risk of depressive symptomatology in older adults: findings from the health, aging, and body composition study. Biol Psychiatry. 2008;64(4):320–326.
   PubMed Web of Science ®Google Scholar
• Carney RM, Freedland KE. Depression in patients with coronary heart disease. Am J Med. 2008;121(11):S20–S7.
   PubMed Web of Science ®Google Scholar
• Rallidis LS, Varounis C, Sourides V, et al. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease. Curr Med Res Opin. 2011;27(7):1407–1413.
   PubMed Web of Science ®Google Scholar
• Capuron L, Ravaud A, Neveu PJ, et al. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry. 2002;7(5):468–473.
   PubMed Web of Science ®Google Scholar
• Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285(19):2481–2485.
   PubMed Web of Science ®Google Scholar
• Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18(9):963–974.
   PubMed Web of Science ®Google Scholar
• Eriksen S, Bjorklof GH, Helvik AS, et al. The validity of the hospital anxiety and depression scale and the geriatric depression scale-5 in home-dwelling old adults in Norway. J Affect Disord. 2019;256:380–385.
   PubMed Web of Science ®Google Scholar
• Laudisio A, Antonelli Incalzi R, Gemma A, et al. Definition of a Geriatric Depression Scale cutoff based upon quality of life: a population-based study. Int J Geriatr Psychiatry. 2018;33(1):e58–e64.
   PubMed Web of Science ®Google Scholar
• Mackin RS, Insel P, Tosun D, et al. The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment. Am J Geriatr Psychiatry. 2013;21(9):906–914.
   PubMed Web of Science ®Google Scholar
• Drouet L. Atherothrombosis as a systemic disease. Cerebrovasc Dis. 2002;13(Suppl 1):1–6.
   PubMedGoogle Scholar